Skip to main content
Premium Trial:

Request an Annual Quote

George Church, John Halamka, Esther Dyson, Misha Angrist, Kirk Maxey, Rosalynn Gill-Garrison, James Sherley, Stan Lapidus, Karin Remington, Rita Colwell, Collis Woodward

Harvard University’s George Church has disclosed the first participants in the Personal Genome Project, an effort that aims to publish the complete genomes and medical records of several volunteers in order to advance personalized medicine. These participants, which gave Church permission to disclose their identities to In Sequence, include John Halamka, Chief Information Officer of Harvard Medical School; Esther Dyson, former chairman of the ICANN board and currently chairman of EDventure Holdings; Misha Angrist, science editor at the Duke Institute for Genome Sciences and Policy; Kirk Maxey, president of Cayman Chemical; Keith Batchelder, CEO of Genomic Healthcare Strategies; Rosalynn Gill-Garrison, chief science officer of Sciona; James Sherley, a stem cell biologist at the Massachusetts Institute of Technology, and Stan Lapidus, president and CEO of Helicos BioSciences.

The National Institute of General Medical Sciences has appointed Karin Remington as director of the Center for Bioinformatics and Computational Biology. Remington will oversee more than 1,300 research and training grants totaling about $89 million to support bioinformatics and computational biology projects. CBCB also oversees NIH's Biomedical Information Science and Technology Initiative and partners with the National Science Foundation to support research and training in mathematical biology.
Remington most recently served as the project manager for the National Ecological Observatory Network. Prior to that,she was vice president of bioinformatics research at the J. Craig Venter Institute from 2002 to 2006. She worked at Celera Genomics from 1999 to 2002, where she developed mathematical methods for analyzing the fruit fly, human, and mouse genomes.

Rita Colwell was among last week's winners of the National Science Foundation’s 2006 National Medals of Science and Technology. Colwell is a former NSF director and is currently a director of the J. Craig Venter Institute.

Collis Woodward has been tapped as vice president and CEO of VisioNetx, a subsidiary of diagnostic developer AcuNetx that focuses on ocular scanning technologies. Woodward previously served as CFO for encryptX, a security software company. He was a founder, chief financial officer, and director of Acculabs; a founder and director of Westerly Partners; and CEO of UVP, a manufacturer and distributor of ultraviolet light products and DNA sequencing software.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.